Fig. 4From: Pyroglutamate and Isoaspartate modified Amyloid-Beta in ageing and Alzheimer’s diseaseCorrelation analysis. Representation of the most significant correlations (p < 0.01) observed in the AD, OC and YC cohortsBack to article page